Technical Analysis for BDSI - BioDelivery Sciences International, Inc.

Grade Last Price % Change Price Change
grade D 4.81 1.48% 0.07
BDSI closed up 1.48 percent on Friday, June 5, 2020, on 1.19 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Flat
Historical BDSI trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Fell Below 20 DMA Bearish 1.48%
20 DMA Support Bullish 0.84%
Spinning Top Other 0.84%
20 DMA Support Bullish 0.84%
20 DMA Support Bullish 0.63%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.63%
Down 3 Days in a Row Weakness 0.63%
Down 4 Days in a Row Weakness 0.63%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapeutics in the areas of pain management and oncology supportive care. The company uses its patented BioErodible MucoAdhesive (BEMA) drug delivery technology that consists of a small, bi-layered erodible polymer film for application to the buccal mucosa in the development of its products. Its products include ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in opioid tolerant adult patients with cancer; BEMA Buprenorphine that is in Phase III trial for the treatment of moderate to severe chronic pain in a mixed opioid naïve and opioid experienced population; BEMA Buprenorphine/Naloxone, which is in development stage for the treatment of opioid dependence; and BEMA Granisetron for the prevention of nausea and vomiting associated with cancer therapies. The company has a licensing and development agreement with Endo Pharmaceuticals, Inc. to develop and commercialize BEMA Buprenorphine. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.
Cancer Pharmaceutical Pain Drugs Pain Management Euphoriants Cancer Therapies Morphinans Opioids Nausea Fentanyl Severe Chronic Pain Vomiting Buprenorphine Drug Delivery Technology Drug Rehabilitation Opioid Opioid Antagonists Breakthrough Pain Naloxone

Is BDSI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.21
52 Week Low 2.85
Average Volume 920,859
200-Day Moving Average 5.06
50-Day Moving Average 4.40
20-Day Moving Average 4.75
10-Day Moving Average 4.81
Average True Range 0.23
ADX 26.79
+DI 30.77
-DI 18.46
Chandelier Exit (Long, 3 ATRs ) 4.69
Chandelier Exit (Short, 3 ATRs ) 4.93
Upper Bollinger Band 5.09
Lower Bollinger Band 4.41
Percent B (%b) 0.59
BandWidth 14.43
MACD Line 0.09
MACD Signal Line 0.11
MACD Histogram -0.0169
Fundamentals Value
Market Cap 266.83 Million
Num Shares 55.5 Million
EPS 0.03
Price-to-Earnings (P/E) Ratio 160.33
Price-to-Sales 3.69
Price-to-Book 6.22
PEG Ratio 0.98
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.07
Resistance 3 (R3) 5.07 5.00 5.02
Resistance 2 (R2) 5.00 4.93 4.99 5.01
Resistance 1 (R1) 4.90 4.89 4.87 4.90 4.99
Pivot Point 4.83 4.83 4.81 4.82 4.83
Support 1 (S1) 4.73 4.76 4.70 4.73 4.63
Support 2 (S2) 4.66 4.72 4.65 4.61
Support 3 (S3) 4.56 4.66 4.60
Support 4 (S4) 4.56